cysteine-type endopeptidase activity involved in apoptotic process
about
Caspase 1Caspase 9Caspase 8Caspase 2Caspase 3Caspase 6Caspase 12 (gene/pseudogene)Caspase 4Caspase 5PYD and CARD domain containingCharcot-Leyden crystal galectinCaspase 7CASP8 and FADD like apoptosis regulatorCaspase 12Galectin-10Caspase 6Caspase 14Caspase 4, apoptosis-related cysteine peptidaseCaspase 7CASP8 and FADD-like apoptosis regulatorPYD and CARD domain containingCaspase 10Caspase 3Caspase 8Caspase 2Caspase 12PYD and CARD domain containingCaspase 7Caspase 14Caspase 4Hypothetical protein CELE_ZK795.2Putative inactive caspase subunit p14 CELE_Y73B6BL.7Caspase A subunit p16 CELE_Y48E1B.13Cell death protein 3 subunit p17 CELE_C48D1.2Ser/Thr-rich caspase Dmel_CG7863Death regulator Nedd2-like caspase Dmel_CG8091Death associated molecule related to Mch2 caspase Dmel_CG18188Death related ICE-like caspase Dmel_CG7788Death caspase-1 Dmel_CG5370Death executioner caspase related to Apopain/Yama Dmel_CG14902
P680
The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung diseaseThe human papillomavirus-16 E7 oncoprotein exerts antiapoptotic effects via its physical interaction with the actin-binding protein gelsolinHuman caspase 12 has acquired deleterious mutationsHuman CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive functionA dominant autoinflammatory disease caused by non-cleavable variants of RIPK1
P921
Q14901975-23D7F54A-A5AB-4550-BBE7-E61EF0A09B7DQ14907717-13CD8D6F-6995-4764-B2C8-24D870C387C7Q14911968-66F6E356-8A84-419D-942F-8C5D25841CD7Q14911968-B2376EC7-E9AC-49C2-943A-53FF7DBB0B23Q14913278-0E1EC693-420E-45A9-A122-63BE9BD61C27Q14913278-63AB9569-CC88-4C79-BBA3-B4A202FE24F9Q14914375-43F14478-BE94-4D4B-961E-840E7A4BBA49Q14914375-D33A60CE-91D4-4290-A5D5-85B163DC521DQ21100551-1AED8D6A-C828-4BA1-A757-7A840DC60BD0Q21100576-34E22634-26BF-48CE-B383-AA6195C27763Q21100576-9C52C91D-ACCC-4E14-9209-3AC740EA8036Q21111755-9452F1A2-0892-4D08-B5BA-9807E136381FQ21112956-412EC49A-18D9-4709-8C67-C6CE76182E0BQ21116456-1EFDDF97-352C-48CF-976A-9871205D4CECQ21120764-E3F1076D-446F-4B1D-9FE8-A6B5676EEBC8Q21131812-13CE5A36-8F34-44FD-B5EB-DAFC83936189Q21151736-F87DDD0F-A711-4071-A2A1-7A332DD76BE0Q21428218-D361CFD8-E0C2-4386-AF2E-49FA1CB87576Q21436521-448EE91F-6DE4-43A2-B2F7-18F667B9AFA0Q21494935-DFF0BF17-3AD0-46C2-9ABB-999F31CAB1ECQ21494937-652C2102-13C4-4F76-8F4B-DC639FA5FACFQ21494941-59333D7F-DEBE-46D3-B70E-612BA427DDCCQ21494943-568BE82A-2BAE-40DA-A559-9788F6C5752BQ21494943-B875E555-B007-4528-9B1B-5DEE7EB7F155Q21495069-C6A621D5-C2B5-490F-8555-CA50FFAE1A66Q21497006-BEF06C63-4C02-4846-B4D1-DC93D2548DA1Q22679036-D22EE579-5EE1-4FD6-8545-32E50D54EFBFQ28556619-45BA0910-D27F-496A-9234-FE58CA0A1A7EQ28560308-88C0BE6F-D6E6-4475-815D-0036B0639665Q28561007-8596E605-0063-45DA-A420-E063B49EB5ADQ28563267-2B2A0AAA-69CA-4075-917F-2A3B7DB3419CQ29518600-AC2DE2A5-1F3E-450F-B3D7-8473269DC943Q29522487-EB1928D3-1F76-4A4B-B69C-E48DB9CCD6CDQ29524252-65BE747A-75FA-4ED0-B8E3-F16D294E7511Q29524463-98D73F56-479B-47B6-96E9-C8B08A11515EQ29792795-4A250C30-DE3F-45BC-B893-79FA3A30201FQ29796457-2D91B602-D23C-48AE-98E1-8860C863A7F6Q29798438-4193CD67-12CA-4AB1-8C5F-94C76E69E74FQ29801550-F5D7D8A8-BF7F-4944-AFA1-9B381BFAD51AQ29809490-4CD11EB1-6A7D-4257-8D7F-FB8156CD31F0
P680
cysteine-type endopeptidase activity involved in apoptotic process
description
Catalysis of the hydrolysis of ...... ting to the apoptotic process.
@en
biologisch proces
@nl
name
cysteine-type endopeptidase activity involved in apoptotic process
@en
type
label
cysteine-type endopeptidase activity involved in apoptotic process
@en
altLabel
GO:0097153
@en
prefLabel
cysteine-type endopeptidase activity involved in apoptotic process
@en
P2888
P686
GO:0097153